Charles Brandes acquired 2.9 Million Takeda Pharmaceutical Co shares worth $38.7 Million. That's 0.52% of their equity portfolio (64th largest holding). The first Takeda Pharmaceutical Co trade was made in Q4 2018. Since then Charles Brandes bought shares eleven more times and sold shares on ten occasions. The investor's estimated purchase price is $47.4 Million, resulting in a loss of 18%.